Stewart Jeffrey Ryan 4
4 · AbbVie Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
AbbVie EVP Jeffrey Ryan Surrenders 23,812 Shares for Taxes
What Happened
- Jeffrey Ryan, Executive Vice President and Chief Commercial Officer of AbbVie (ABBV), disposed of 23,812 shares on 2026-02-27 to satisfy a tax or exercise-related obligation. The shares were valued at $232.08 each, for a total of $5,526,289. This was a tax-withholding/net-share settlement event (routine), not an open-market sale meant as a directional trade.
Key Details
- Transaction date and price: 2026-02-27 at $232.08 per share.
- Shares disposed: 23,812; total value ≈ $5,526,289.
- Shares owned after transaction: Not specified in this filing.
- Footnote: The reporting person disclaims beneficial ownership of securities held by his spouse (F1).
- Filing: Reported on 2026-03-03; appears to be filed in the normal timeframe.
Context
- Code F indicates payment of an exercise price or tax liability (often a net-share settlement when options vest or RSUs vest). Such disposals are typically routine to cover withholding and do not necessarily signal the insider’s view on the company’s prospects.
- For retail investors, purchases are generally more informative about insider sentiment; tax-withholding disposals are common and primarily administrative.
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
Transactions
- Tax Payment
Common Stock, $0.01 par value
2026-02-27$232.08/sh−23,812$5,526,289→ 83,171 total
Holdings
- 1,338(indirect: By Trust)
Common Stock, $0.01 par value
[F1]
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of all securities held by his spouse.
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Jeffrey R. Stewart|2026-03-03